Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Abivax develops medicines that alter the body's natural immune system mechanisms.
Unrivaled Sports manages a diverse portfolio of youth sports properties in Baseball, Softball, Football, and Action Sports.
Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.
audiochuck is a media company that creates and produces content.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.
The operating system for stablecoins.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Better Place Forests provides memorial spreading forests for families who choose cremation.
TCG has invested in 153 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
TCG's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Biopharma. The firm invests across 25 different industry categories.
Among tracked funding rounds, Abivax received $747.5M in a Post Ipo Equity round. TCG's total known invested capital is $1.8B.
TCG's average investment size is $24.7M across its portfolio of 153 companies.
Recent TCG portfolio additions include Rapt Therapeutics, ADC Therapeutics, Affinia Therapeutics, Cidara Therapeutics, Maze Therapeutics. These companies were founded in 2020 or later.